Palmitoyl Tetrapeptide-7 (Rigin)
No pricing data available yet for this peptide.
Pricing data is updated regularly.
Palmitoyl Tetrapeptide-7 reduces interleukin-6 (IL-6) production, decreasing chronic inflammation that accelerates skin aging. It complements collagen-stimulating peptides by addressing inflammaging, protects against glycation, and helps maintain skin barrier integrity and youthful appearance.
| Level | Amount | Frequency | Timing |
|---|---|---|---|
| Beginner | Topical 50 ppm | Once daily | Evening |
| Standard | Topical 100 ppm | Twice daily | Morning and evening |
| Advanced | Combined with Matrixyl 3000 | Twice daily | As part of peptide complex |
Ongoing topical use
Variable (topical)
Pre-formulated in topical products
Cool, dry place
Per product instructions
Explore peer-reviewed studies and clinical research on Palmitoyl Tetrapeptide-7
Peer-reviewed medical research
Active and completed clinical trials
Academic papers and citations
Evidence-based supplement analysis
Research Disclaimer: These links lead to external research databases. Always consult with a qualified healthcare provider before making decisions based on research literature.
This information is provided for educational and research purposes only. It is not intended as medical advice, diagnosis, or treatment recommendation. Consult a licensed healthcare professional before using any peptide. BioProtocol does not sell peptides or pharmaceutical products.